XML 96 R86.htm IDEA: XBRL DOCUMENT v3.24.0.1
Segment Information (Tabulation of Business Segment Information Based on Current Segmentation) (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Segment Reporting Information [Line Items]        
Total Consolidated Revenue $ 393,242 $ 362,834 $ 762,087 $ 717,103
Total consolidated adjusted operating income 75,569 77,905 138,878 144,672
Restructuring expense (68) (1,363) (744) (16,428)
Business integration expense (6,909) (14,816) (12,171) (24,356)
Litigation reserve 0 0 (18,500) 0
Loss on assets held for sale (647) 0 (647) 0
Total consolidated operating income 58,612 45,550 86,806 69,184
Interest expense (16,693) (15,589) (32,350) (33,349)
Other income (expense), net 3,563 (1,440) 5,777 (679)
Total consolidated income from continuing operations before income taxes 45,482 28,521 60,233 35,156
Total Consolidated capital expenditures 15,282 4,196 30,328 9,747
Total consolidated depreciation expense 10,936 10,656 20,714 21,461
Total consolidated intangible amortization expense (9,333) (16,176) (20,010) (34,704)
Chamberlain        
Segment Reporting Information [Line Items]        
Total Consolidated Revenue 153,553 141,396 296,149 276,801
Walden University        
Segment Reporting Information [Line Items]        
Total Consolidated Revenue 146,808 131,940 288,416 262,841
Medical and Veterinary        
Segment Reporting Information [Line Items]        
Total Consolidated Revenue 92,881 89,498 177,522 177,461
Operating Segments [Member] | Chamberlain        
Segment Reporting Information [Line Items]        
Total Consolidated Revenue 153,553 141,396 296,149 276,801
Total consolidated adjusted operating income 29,640 33,229 53,964 60,231
Total Consolidated capital expenditures 5,757 1,492 11,042 2,918
Total consolidated depreciation expense 5,162 4,099 9,478 8,580
Operating Segments [Member] | Walden University        
Segment Reporting Information [Line Items]        
Total Consolidated Revenue 146,808 131,940 288,416 262,841
Total consolidated adjusted operating income 30,155 29,012 61,270 53,553
Total Consolidated capital expenditures 2,619 268 5,561 1,093
Total consolidated depreciation expense 2,305 2,269 4,467 4,864
Total consolidated intangible amortization expense (9,333) (16,176) (20,010) (34,704)
Operating Segments [Member] | Medical and Veterinary        
Segment Reporting Information [Line Items]        
Total Consolidated Revenue 92,881 89,498 177,522 177,461
Total consolidated adjusted operating income 22,091 22,549 36,568 39,613
Restructuring expense (71) (87) (185) (6,913)
Total Consolidated capital expenditures 1,935 342 3,280 915
Total consolidated depreciation expense 3,110 3,031 6,054 6,136
Corporate, Non-Segment [Member]        
Segment Reporting Information [Line Items]        
Total consolidated adjusted operating income (6,317) (6,885) (12,924) (8,725)
Total Consolidated capital expenditures 4,971 2,094 10,445 4,821
Total consolidated depreciation expense $ 359 $ 1,257 $ 715 $ 1,881